Neuroone Medical Technologies (NMTC) Cash & Current Investments (2017 - 2026)
Neuroone Medical Technologies' (NMTC) quarterly Cash & Current Investments came in at $2.8 million in Q1 2026, up 112.08% YoY from $1.3 million in Q1 2025, and down 21.38% on a QoQ basis from $3.6 million in Q4 2025.
Neuroone Medical Technologies (NMTC) Cash & Current Investments (2017 - 2026) Analysis & Trends
Neuroone Medical Technologies (NMTC) has 10 years of Cash & Current Investments data on file, last reported at $2.8 million in Q1 2026.
- Quarterly Cash & Current Investments rose 112.08% year-over-year to $2.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.8 million (up 112.08% YoY) and the FY2025 annual result came in at $6.6 million, up 350.01% from the prior year.
- Cash & Current Investments fell to $2.8 million in Q1 2026, from $3.6 million in the prior quarter.
- In the past five years, Cash & Current Investments ranged from a high of $12.9 million in Q1 2022 to a low of $1.1 million in Q4 2024.
- A 5-year average of $5.1 million and a median of $3.6 million in 2025 frame the typical range for Cash & Current Investments.
- Annual changes were most pronounced in 2024 — Cash & Current Investments slumped 72.57% — and 2025, when it soared 393.83%.
- Tracing NMTC's Cash & Current Investments over 5 years: stood at $7.6 million in 2022, then slumped by 64.92% to $2.7 million in 2023, then slumped by 57.69% to $1.1 million in 2024, then jumped by 213.98% to $3.6 million in 2025, then fell by 21.38% to $2.8 million in 2026.
- The last three Cash & Current Investments figures came in at $2.8 million (Q1 2026), $3.6 million (Q4 2025), and $6.6 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn | 5.60 Bn |
| 2 | Stryker | 127.41 Bn | 123.93 Bn | 4.50 Bn | 3.48 Bn |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 9.22 Bn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 539.00 Mn |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.69 Bn | 1.35 Bn | 4.25 Bn |
| 6 | Dexcom | 34.30 Bn | 32.35 Bn | 830.00 Mn | 1.95 Bn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 2.11 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn | 3.32 Bn |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn | 482.30 Mn |
| 10 | Neuroone Medical Technologies | 19.38 Mn | 17.33 Mn | 1.18 Mn | 2.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.05 Mn |
| Mar 31, 2026 | 2.80 Mn |
| Dec 31, 2025 | 3.56 Mn |
| Sep 30, 2025 | 6.57 Mn |
| Jun 30, 2025 | 8.00 Mn |
| Mar 31, 2025 | 1.32 Mn |
| Dec 31, 2024 | 1.13 Mn |
| Sep 30, 2024 | 1.46 Mn |
| Jun 30, 2024 | 1.62 Mn |
| Mar 31, 2024 | 2.43 Mn |
| Dec 31, 2023 | 2.68 Mn |
| Sep 30, 2023 | 5.32 Mn |
| Jun 30, 2023 | 3.08 Mn |
| Mar 31, 2023 | 4.60 Mn |
| Dec 31, 2022 | 7.64 Mn |
| Sep 30, 2022 | 11.14 Mn |
| Jun 30, 2022 | 10.18 Mn |
| Mar 31, 2022 | 12.87 Mn |
| Dec 31, 2021 | 16.18 Mn |
| Sep 30, 2021 | 6.90 Mn |